More on CYTK
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $78.11 |
|
|||
| Open | $79.41 | ||||
| 52 Wk High | $13.18 | ||||
| 52 Wk Low | $6.00 | ||||
| Day High | $80.15 | ||||
| Day Low | $77.14 | ||||
| P/E | N/A | ||||
| EPS | $-1.24 | ||||
| Volume | 3,547,472 | ||||
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- RBC Capital on Cytokinetics (CYTK): 'The stock is significantly undervalued despite today's move'
- Form 4 CYTOKINETICS INC For: Jun 15 Filed by: Blum Robert I
- Form 4 CYTOKINETICS INC For: Jun 09 Filed by: Malik Fady Ibraham
- Cytokinetics Announces Call for Proposals for Annual Corporate Giving Program
- Form 4 CYTOKINETICS INC For: Jun 01 Filed by: Kaye Edward M. MD
- Form 4 CYTOKINETICS INC For: Jun 01 Filed by: Callos Andrew
- Form 4 CYTOKINETICS INC For: Jun 01 Filed by: PARSHALL B LYNNE
- Form 144 CYTOKINETICS INC Filed by: Kaye Edward M. MD
- Cytokinetics launches MYQORZO in Germany, first EU market
Entities mentioned with CYTK
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- PDUFA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- AdCom | View Related Stories »
- Show More...
